Vanguard Group
HURA

Vanguard Group’s TuHURA Biosciences HURA Stock Holding History

Vanguard Group’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.76M Buy
2,319,762
+50,096
+2% +$95.9K ﹤0.01% 3603
2025
Q3 		$5.63M Buy
2,269,666
+35,426
+2% +$93.2K ﹤0.01% 3232
2025
Q2 		$4.98M Buy
2,234,240
+358,707
+19% +$1.21M ﹤0.01% 3220
2025
Q1 		$6.06M Buy
1,875,533
+1,499,214
+398% +$5.53M ﹤0.01% 3101
2024
Q4 		$1.54M Buy
376,319
+375,963
+105,608% +$2M ﹤0.01% 3638
2024
Q3 		$2.43K Hold
356
– – ﹤0.01% 4349
2024
Q2 		$3.36K Hold
356
– – ﹤0.01% 4412
2024
Q1 		$1.29K Hold
356
– – ﹤0.01% 4448
2023
Q4 		$2.11K Hold
356
– – ﹤0.01% 4495
2023
Q3 		$50.3K Buy
+356
New +$52.5K ﹤0.01% 4414
2023
Q1 		– Sell
-424
Closed -$102K – 4583
2022
Q4 		$102K Buy
424
+1
+0.2% +$222 ﹤0.01% 4394
2022
Q3 		$80K Sell
423
-387
-48% -$124K ﹤0.01% 4510
2022
Q2 		$394K Hold
810
– – ﹤0.01% 4346
2022
Q1 		$564K Hold
810
– – ﹤0.01% 4372
2021
Q4 		$723K Buy
810
+167
+26% +$226K ﹤0.01% 4355
2021
Q3 		$969K Buy
643
+2
+0.3% +$5.25K ﹤0.01% 4252
2021
Q2 		$2.55M Buy
641
+321
+100% +$922K ﹤0.01% 3899
2021
Q1 		$975K Buy
320
+309
+2,809% +$1.05M ﹤0.01% 4015
2020
Q4 		$25K Buy
11
+1
+10% +$2.51K ﹤0.01% 4197
2020
Q3 		$25K Buy
+10
New +$20.1K ﹤0.01% 4092

Other funds holding HURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vanguard Group's HURA Position: Q4 2025 in Review

Vanguard Group increased its TuHURA Biosciences (HURA) stake by 2.2% in Q4 2025, buying an estimated $95.9K and bringing the position to 2,319,762 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

Vanguard Group first reported a position in HURA in Q3 2020 and has held it in 20 quarters since. The position peaked at $6.06M in Q1 2025. 65 funds tracked by Wall St. Rank hold HURA as of Q4 2025.

  • Vanguard Group held 2,319,762 shares of TuHURA Biosciences worth $1.76M as of Q4 2025.
  • Vanguard Group bought 50,096 TuHURA Biosciences shares in Q4 2025, an estimated $95.9K.
  • TuHURA Biosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3603 holding.
  • Vanguard Group first reported a position in TuHURA Biosciences in Q3 2020 and has held it in 20 quarters since.
  • Vanguard Group's TuHURA Biosciences position peaked at $6.06M in Q1 2025.
  • 65 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.